Drawing for EUPOLIO

USPTO serial 79323848

EUPOLIO

Reviewed by CopyMark Law Group

Reg. 6903466Status 700Registered
Filing date
Status date
Registration date
Nov 22, 2022
Examiner
CARR, PATRICK C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EUPOLIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles T. J. Weigell

Charles T. J. Weigell Fross Zelnick Lehrman & Zissu, P.C.151 W 42nd Street 17th FloorNew York, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Sugar substitutes for diabetics, namely, dietetic sugar substitutes for medical use; pharmaceutical preparations for the prevention of diabetes; chemical preparations for the diagnosis of diabetes; pharmaceutical preparations for treating diabetes; vaccines for the prevention of herpes zoster; pharmaceutical preparations for treating herpes zoster; pharmaceutical agents affecting peripheral nervous system; viral vaccines; vaccines; adjuvants for use with vaccines; pharmaceutical preparations for the treatment of cells being pharmaceutical preparations for treating chemical imbalances; pharmaceutical preparations for the prevention of disorders of the nervous system; drugs for medical purposes, namely, medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceuticals for human and animal use, namely, pharmaceutical preparations for wounds; medicines for human purposes, namely, medicines for alleviating constipation; pharmaceutical preparations acting on the central nervous system; antidiabetic preparations; antiviral preparations, namely, pharmaceutical preparations in the nature of antivirals; human vaccine preparations; polio vaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 12, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 17, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 17, 2023FIMPFINAL DISPOSITION PROCESSED—
Feb 22, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 22, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 22, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 6, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 6, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 17, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 29, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 14, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 14, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 14, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 30, 2022RFNTREFUSAL PROCESSED BY IB—
May 10, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 10, 2022RFRRREFUSAL PROCESSED BY MPU—
Mar 29, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 28, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2022DOCKASSIGNED TO EXAMINER—
Nov 3, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 30, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 22, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance